Cronos Group Inc. (TSE:CRON – Get Free Report) shares traded up 5% on Wednesday . The stock traded as high as C$2.75 and last traded at C$2.74. 84,202 shares changed hands during trading, a decline of 63% from the average session volume of 225,730 shares. The stock had previously closed at C$2.61.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the stock. Jefferies Financial Group cut their target price on shares of Cronos Group from C$2.63 to C$2.61 in a research note on Wednesday, August 16th. Sanford C. Bernstein cut their target price on shares of Cronos Group from C$3.04 to C$2.84 and set a “market perform” rating on the stock in a research note on Monday, September 18th.
Cronos Group Price Performance
About Cronos Group
Cronos Group Inc operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.
- Five stocks we like better than Cronos Group
- Consumer Discretionary Stocks Explained
- Should you buy Western Digital and sell Seagate stock?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Lucid investors seek clarity; downtrend intact, new lows ahead
- What is the FTSE 100 index?
- Celsius is growing with no end in sight!
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.